On-time vaccination coverage in premature infants in Ontario, 2002-2009

Kumanan Wilson1, Steven Hawken, Kirsten Holdt Henningsen

  • 1Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON. kwilson@ohri.ca

Insights

Premature infants, especially those extremely premature, show lower on-time vaccination rates. Hospitalization status significantly impacts these vaccination schedules for vulnerable infants.

Area of Science:

  • Pediatrics
  • Public Health
  • Immunization

Background:

  • Premature infants face higher risks from vaccine-preventable diseases.
  • Routine childhood vaccinations are recommended at the same chronological age for all infants, with specific exceptions.

Purpose of the Study:

  • To compare on-time vaccination levels in premature infants versus full-term infants.
  • To identify disparities in timely immunization for different categories of premature births.

Main Methods:

  • Utilized linked health administrative databases in Ontario.
  • Compared on-time vaccination rates at 2, 4, and 6 months for term, near-term, very premature, and extremely premature infants.
  • Analyzed data with and without exclusion of hospitalized infants.

Main Results:

  • Excluding hospitalized infants, vaccination rates were similar across all groups (within 3%).
  • Including hospitalized infants revealed significantly lower on-time vaccination rates for extremely premature infants at 2 and 4 months.
  • Very premature infants also showed lower on-time rates at 2 months when hospitalization was considered.

Conclusions:

  • Hospitalization status is a critical factor influencing on-time vaccination for premature infants.
  • There is a need to verify if vaccinations are administered during hospitalization for scheduled infant immunization.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...